BOYS MARK LAURENCE,BOYS Mark Laurence,DELISLE ROBERT KIRK,DELISLE Robert Kirk,HICKEN ERIK JAMES,HICKEN Erik James,KENNEDY APRIL L.,KENNEDY April L.,MARESKA DAVID A.,MARESKA David A.,MARMSATER FREDRIK
申请号:
SI201130508
公开号:
SI2651939T1
申请日:
2011.12.13
申请国别(地区):
SI
年份:
2015
代理人:
摘要:
Compounds of Formula I: and pharmaceutically acceptable salts thereof in which R1, R2, R3, R4, R5 and R6 have the meanings given in the specification, are inhibitors of cFMS and are useful in the treatment of fibrosis, bone-related diseases, cancer, autoimmune disorders, inflammatory diseases, cardiovascular diseases, pain and burns in a mammal.